Comment on ‘Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results’ – (Eye 29, 1630 (December 2015))
Comment on ‘Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results’ Eye 29, 1630 (December 2015). doi:10.1038/eye.2015.190 Author: V P Dave
Annual acknowledgement of manuscript reviewers – (Eye 29, 1517 (December 2015))
Annual acknowledgement of manuscript reviewers Eye 29, 1517 (December 2015). doi:10.1038/eye.2015.229 Author:
RCOphth concerned at the continued restriction of second eye cataract surgery by CCGs
The Royal College of Ophthalmologists is concerned to hear that there continues to be a restriction of second eye cataract surgery by some CCGs. The RCOphth stresses that the decision to perform second eye cataract surgery should be based entirely on clinical need. A report by the Scottish Health Technologies Group (Healthcare Improvement Scotland) identified evidence
Ranibizumab for the treatment of wet AMD: a summary of real-world studies – (Eye Journal AOP)
Ranibizumab for the treatment of wet AMD: a summary of real-world studies Eye advance online publication, December 4 2015. doi:10.1038/eye.2015.217 Author: V Chong
How safe is the light during ophthalmic diagnosis and surgery – (Eye Journal AOP)
How safe is the light during ophthalmic diagnosis and surgery Eye advance online publication, December 4 2015. doi:10.1038/eye.2015.247 Author: M Wolffe